The final NRDL and commercial insurance covered innovative drug list will be decided in November at the latest after further evaluations and pricing negotiations in September and October. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
